Jonathan Berlent serves as Executive at Cure Pharmaceutical Holding Corp., where they oversee executive responsibilities. Since joining the company, Jonathan Berlent has executed 1 insider transactions totaling $6.9K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 27, 2021 involved purchasing 10,000 shares valued at $6.9K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 27, 2021 | CURR | $6.9K | Purchase | 10,000 | $0.69 | Discretionary |
Jonathan Berlent currently holds 10,000 shares of Cure Pharmaceutical Holding Corp. (CURR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Berlent has been a net buyer of CURR stock. They have purchased $6.9K and sold $0 worth of shares.
Jonathan Berlent's most recent insider trade was on May 27, 2021, when they purchased 10,000 shares at $0.69 per share.
Get notified when new Form 4 filings are submitted